The Extraction and High Antiproliferative Effect of Anthocyanin from Gardenblue Blueberry

• Published in: Molecules (Basel, Switzerland) Switzerland), 2023-03, Vol.28 (6), p.2850
• Main Authors: Zhao, Fengyi, Wang, Jialuan, Wang, Weifan, Lyu, Lianfei, Wu, Wenlong, Li, Weilin
• Format: Article
• Language: English
• Subjects: Agricultural societies; Anthocyanin; Anthocyanins; Anthocyanins - pharmacology; Antioxidants - pharmacology; antiproliferative effect; Antiproliferatives; Apoptosis; Berries; Biocompatibility; Blueberries; blueberry; Blueberry Plants; Breast cancer; Cancer therapies; Cell cycle; Cell growth; Cell Proliferation; Cervical cancer; Cisplatin; Colorectal cancer; Deoxyribonucleic acid; DNA; Doxorubicin; Drug dosages; Flavonoids; Flavonoids - pharmacology; Fruit; Fruits; functional components; Gardens & gardening; Glucose; Hepatocytes; Hepatoma; Humans; Investigations; Kinases; Liver cancer; Lung cancer; Organic acids; Phenolic acids; Phenols; Phytochemicals; Plant Extracts - pharmacology; Polyphenols; Signal transduction; Skin cancer; Solvent extraction; Toxicity; Vaccinium
• ISSN: 1420-3049; 1420-3049
• DOI: 10.3390/molecules28062850

Blueberries are rich in flavonoids, anthocyanins, phenolic acids, and other bioactive substances. Anthocyanins are important functional components in blueberries. We collected 65 varieties of blueberries to investigate their nutritional and functional values. Among them, Gardenblue had the highest anthocyanin content, with 2.59 mg/g in fresh fruit. After ultrasound-assisted solvent extraction and macroporous resin absorption, the content was increased to 459.81 mg/g in the dried powder. Biological experiments showed that Gardenblue anthocyanins (L ) had antiproliferative effect on cervical cancer cells (Hela, 51.98 μg/mL), liver cancer cells (HepG2, 23.57 μg/mL), breast cancer cells (MCF-7, 113.39 μg/mL), and lung cancer cells (A549, 76.10 μg/mL), and no apparent toxic effects were indicated by methyl thiazolyl tetrazolium (MTT) assay, especially against HepG2 cells both in vitro and in vivo. After combining it with DDP (cisplatin) and DOX (doxorubicin), the antiproliferative effects were enhanced, especially when combined with DOX against HepG2 cells; the IC value was 0.02 μg/mL. This was further evidence that L could inhibit cell proliferation by inducing apoptosis. The detailed mechanism might be L interacting with DNA in an intercalation mode that changes or destroys DNA, causing apoptosis and inhibiting cell proliferation. The findings of this study suggest that L extract can be used as a functional agent against hepatoma carcinoma cells.